On Friday, Eli Lilly (LLY) won approval of Mounjaro (tirzepatide), a novel once-weekly injectable medicine for type 2 diabetes.
in Health care
Why the approval of Eli Lilly’s tirzepatide for diabetes will lead to blockbuster sales




GIPHY App Key not set. Please check settings